广生堂(300436.SZ)：暂未有创新药项目对外授权

Core Viewpoint - The company, Guangshentang (300436.SZ), currently has no innovative drug projects authorized for external collaboration but is actively exploring opportunities for research and commercialization partnerships to support its innovation and growth [1] Group 1 - The company is closely monitoring market opportunities [1] - The company is actively seeking innovative drug research and commercialization collaboration opportunities [1] - The company will fulfill its information disclosure obligations in case of relevant progress [1]